Time-Varying Mortality Risk Suggests Increased Impact of Thrombosis in Hospitalized Covid-19 Patients
Lengerich, B. J.; Nunnally, M. E.; Aphinyanaphongs, Y. J.; Caruana, R.
Show abstract
Treatment protocols, treatment availability, disease understanding, and viral characteristics have changed over the course of the Covid-19 pandemic; as a result, the risks associated with patient comorbidities and biomarkers have also changed. We add to the ongoing conversation regarding inflammation, hemostasis and vascular function in Covid-19 by performing a time-varying observational analysis of over 4000 patients hospitalized for Covid-19 in a New York City hospital system from March 2020 to August 2021 to elucidate the changing impact of thrombosis, inflammation, and other risk factors on in-hospital mortality. We find that the predictive power of biomarkers of thrombosis risk have increased over time, suggesting an opportunity for improved care by identifying and targeting therapies for patients with elevated thrombophilic propensity.
Matching journals
The top 13 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohort 96%
- Incidence and Risk of Post-COVID-19 Thromboembolic Disease and the Impact of Aspirin Prescription; Nationwide Observational Cohort at the US Department of Veteran Affairs 94%
- The usefulness of D-dimer as a predictive marker for mortality in patients with COVID-19 hospitalized during the first wave in Italy 94%
Similar papers in this journal
- Venous Thromboembolism and the Effects of Statin and Hormone Therapy: A Case-Control Study of 250,000 Women 50-64 years of age 92%
- Corticosteroids in COVID-19: Optimizing Observational Research through Target Trial Emulations 91%
- Score for Emergency Risk Prediction (SERP): An Interpretable Machine Learning AutoScore–Derived Triage Tool for Predicting Mortality after Emergency Admissions 90%
Similar papers in this journal
- A Novel Risk Assessment Model Predicts Major Bleeding Risk at Admission in Medical Inpatients 95%
- Mice with Reduced PAR4 Reactivity show Decreased Venous Thrombosis and Platelet Procoagulant Activity 92%
- POmAb, an antibody targeting open prothrombin, results in anticoagulation without excessive bleeding in mice 91%
Similar papers in this journal
- A Multi-center, Prospective, Observational-cohort controlled study of Clinical Outcomes following COVID-19 Convalescent plasma therapy in hospitalized COVID-19 patients 92%
- SARS-CoV-2 RNAaemia predicts clinical deterioration and extrapulmonary complications from COVID-19 91%
- Pre-existing autoimmunity is associated with increased severity of COVID-19: A retrospective cohort study using data from the National COVID Cohort Collaborative (N3C) 90%
Similar papers in this journal
- The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality from COVID-19 93%
- The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated with Convalescent Plasma 92%
- Is coagulation-protein consumption upon admission linked to COVID-19 severity and mortality? 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.